CIK 0001779578 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in E9 · fiscal year ends 09/30
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-24 | 6-K | FORM 6-K | 2026-09-24 |
| 2026-09-08 | 6-K | FORM 6-K | 2026-09-08 |
| 2026-08-28 | 6-K | FORM 6-K | 2026-08-28 |
| 2026-08-11 | 6-K | FORM 6-K | 2026-08-11 |
| 2026-07-30 | 6-K | FORM 6-K | 2026-07-30 |
| 2026-07-28 | 6-K | FORM 6-K | 2026-07-28 |
| 2026-07-21 | 20-F | 20-F | 2025-09-30 |
| 2026-07-13 | 6-K | FORM 6-K | 2026-07-13 |
| 2026-06-17 | 6-K | FORM 6-K | 2026-06-17 |
| 2026-06-09 | 6-K | FORM 6-K | 2026-06-09 |
| 2026-05-18 | 6-K | FORM 6-K | 2026-05-18 |
| 2026-05-14 | 3 | OWNERSHIP DOCUMENT | 2026-03-31 |
| 2026-05-14 | 3 | OWNERSHIP DOCUMENT | 2026-03-31 |
| 2026-05-14 | 3 | OWNERSHIP DOCUMENT | 2026-03-31 |
| 2026-05-14 | 3 | OWNERSHIP DOCUMENT | 2026-04-28 |
| 2026-05-07 | 6-K | FORM 6-K | 2026-05-07 |
| 2026-04-30 | 6-K | FORM 6-K | 2026-04-30 |
| 2026-04-13 | 3 | PRIMARY DOCUMENT | 2026-04-13 |
| 2026-01-30 | NT 20-F | NT 20-F | 2025-09-30 |
| 2026-01-29 | 6-K | FORM 6-K | 2026-01-29 |
| 2025-12-22 | 6-K | FORM 6-K | 2025-12-18 |
| 2025-08-14 | 6-K | FORM 6-K | 2025-08-14 |
| 2025-07-24 | 6-K | 6-K | 2025-03-31 |
| 2025-06-26 | 6-K | FORM 6-K | 2025-06-26 |
| 2025-06-03 | S-8 | FORM S-8 |
Forms on file (last 1,000): 6-K 56, UPLOAD 16, CORRESP 16, F-1/A 9, 20-F/A 7, 20-F 6, 3 5, NT 20-F 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BGM (0.002 USD), /gw/filings/filings?ticker=BGM&form=8-K, /gw/filings/facts?ticker=BGM&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange